It was revealed that possible mechanisms underlying the antitumor and antimetastatic activity of RNase A include the degradation of circulating RNAs, including microRNAs (miRNAs), and alterations in miRNA patterns in tumor tissue [23]. The gene discussed is RNASE1; the disease is neoplasm.